Fentanyl Citrate Injection · #2 of 35 active shortages by FDA posting duration
FDA lists Fentanyl Citrate Injection as Active Shortage (Hikma Pharmaceuticals USA, Inc.).
Availability on file: Unavailable
Fentanyl Citrate Injection: Active Shortage
Unavailable 19 shortage presentations are tracked for this drug. Contact your pharmacist if you are affected.
Shortage Details
- Generic Name
- Fentanyl Citrate Injection
- Manufacturer
- Hikma Pharmaceuticals USA, Inc.
- Dosage Form
- Injection
- Presentation
- Fentanyl Citrate, Injection, 50 ug/1 mL (NDC 0641-6024-10)
- Package NDC
- 0641-6024-10
Status & Timeline
- Status
- Active Shortage
- Availability
- Unavailable
- First Reported
- Dec 20, 2023
- Last Updated
- Mar 12, 2026
- Therapeutic Category
- Analgesia/Addiction, Pediatric
Row fields from the FDA Drug Shortages database via openFDA.
Shortage Reason
Inventory available in vial presentations.
Full Drug Profile
fentanyl
Side effects, interactions, warnings & more
Nearby, Other Fentanyl Shortage Records
Fentanyl Citrate Injection
Fresenius Kabi USA, LLC
Injection
Fentanyl Citrate Injection
Fresenius Kabi USA, LLC
Injection
Fentanyl Citrate Injection
Hospira, Inc., a Pfizer Company
Injection
Fentanyl Citrate Injection
Hospira, Inc., a Pfizer Company
Injection
Fentanyl Citrate Injection
Hospira, Inc., a Pfizer Company
Injection
Fentanyl Citrate Injection
Hospira, Inc., a Pfizer Company
Injection
FDA reason on file: Inventory available in vial presentations. General shortage guidance lives on the tracker hub.